The snacks were distributed in the state of New York and have been recalled due to undeclared additives and flavor enhancers.

Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security ...

The impacted products have now been given a Class I risk classification by the U.S. Food and Drug Administration.

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

The FDA has issued an urgent recall for shellstock oysters harvested last month in Washington state's Hammersley Inlet.

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Priority review granted for CUTX-101 with PDUFA target action date set for June 30, 2025Cyprium is eligible to receive royalties and up to $129 ...

Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.

In October, the FDA in collaboration with the U.S. Customs and Border Protection (CBP), seized about three million units of ...

Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.